BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220929T133000
DTEND;TZID=Europe/Paris:20220930T190000
DTSTAMP:20220901T132015Z
CREATED:20220616T110326Z
LAST-MODIFIED:20220901T132015Z
UID:19939-1664458200-1664564400@www.bricbordeaux.com
SUMMARY:Kick off meeting BRIC
DESCRIPTION:We are pleased to announce that on September 29-30\, we will be holding the first conference of our new institute\, the BRIC Kick-off meeting. \nThis first event is intended to celebrate the creation of the BRIC and to initiate a series of future symposiums and other congresses within the BRIC. \nThis kick-off meeting will be organized over a day and a half and will include the presentation of the scientific projects of the BRIC members but also of 4 renowned guests: 3 people from SAB Jean-Ehrland Ricci (C3M\, Université Côte d’Azur\, France)\, Ruth Scherz-­Shouval (Weizmann institute of Science\, Israel)\, Urszula Hibner (IGMM\, France) and Phil Jones (The Wellcome Sanger Institute\, Royaume Uni). Finally\, the second day will close with a round table discussion between patient associations and researchers on the theme of patient/researcher collaboration. \n11 sessions are reserved for presentations by BRIC researchers. We already invite each of the team leaders to communicate to us the person who will represent their team during this meeting via this internal link. Presentations by young researchers are welcome. \nA link has been sent to you by email to register for this meeting. Registration is free but mandatory. You also have the possibility to propose abstracts for the poster presentations. The final program will be communicated to you later. \nThe kick off will take place at the Institute of Optics in Talence\, building “Institut d’Optique d’Aquitaine” on line B of the streetcar\, between the stops “Arts et Métiers” and “François Bordes”. \n  \nWe look forward to seeing you at this event! \nOrganizing Committee:\nMonica Arnedos\, Marion Bouchecareilh\, Lucie Brisson\, Vanessa Desplat\, Sandrine Hamon\, Amelie Guitart\, Sarah Lesjean and Catherine Sawai
URL:https://www.bricbordeaux.com/en/event/kick-off-meeting-bric/
LOCATION:Institut d’Optique\, 1 Rue François Mitterrand\, Talence\, 33400\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/flyer-kick-off-meeting-v2022-07-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220915
DTEND;VALUE=DATE:20220917
DTSTAMP:20220720T084906Z
CREATED:20220616T103128Z
LAST-MODIFIED:20220720T084906Z
UID:19925-1663200000-1663372799@www.bricbordeaux.com
SUMMARY:Workshop CGSO Axe 2. Genome Dynamics and Cancer
DESCRIPTION:The steering committee of the Axis 2 “Genome Dynamics and Cancer” and its new coordinators (Eric Julien and Jean-Christophe Andrau) relaunch the face-to-face seminar of the Axis and invite you to meet them on September 15 and 16 in Toulouse. \nFree registration. Registration closes 02 September 12:00
URL:https://www.bricbordeaux.com/en/event/workshop-cgso-axe-2-genome-dynamics-and-cancer/
LOCATION:Toulouse\, Toulouse\, France
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/genom.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220908T170000
DTEND;TZID=Europe/Paris:20220908T180000
DTSTAMP:20230316T165234Z
CREATED:20220905T085110Z
LAST-MODIFIED:20230316T165234Z
UID:20574-1662656400-1662660000@www.bricbordeaux.com
SUMMARY:BRIC Scientific Seminar - Dr Pierre Maisonneuve
DESCRIPTION:The seminar will be followed by a convivial moment with the staff of the BRIC unit
URL:https://www.bricbordeaux.com/en/event/bric-scientific-seminar-dr-pierre-maisonneuve/
LOCATION:Amphithéatre de l’IECB\, 2 rue Robert Escarpit\, Pessac\, 33600\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/affiche-seminaire-p.-maisonneuve-twitter.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220907T120000
DTEND;TZID=Europe/Paris:20220907T130000
DTSTAMP:20230316T165233Z
CREATED:20220901T132659Z
LAST-MODIFIED:20230316T165233Z
UID:20535-1662552000-1662555600@www.bricbordeaux.com
SUMMARY:Oncosphere Interdisciplinary Seminar. Anthony Bouter and Frédéric Saltel
DESCRIPTION:Anthony Bouter\, UMR5248 CBMN\, Bordeaux and Frédéric Saltel\, U1312 BRIC\, Bordeaux will speak at the Oncosphere’s interdisciplinary seminars the 7 septembre at 12pm\,conference room at IBGC and videoconference. \n \nFrédéric Saltel\nBRIC INSERM 1312\, Team 03 – Liver Cancers and Tumor Invasion. \n\n\nCancer cells transfer invasive properties through tracks\, a novel collagen-associated extracellular vesicle entity \nMetastasis is the leading cause of cancer-related deaths. During this process\, tumor cells acquire invasive and migratory capacities in order to invade the surrounding tissues. To achieve this\, the tumor microenvironment including the extracellular matrix (ECM) is altered to facilitate cancer cell proliferation and dissemination. Extracellular vesicles (EVs)\, such as exosomes or migrasomes\, are already known to induce pro-tumor features such as migration\, promoting tumor development and metastasis formation. Here we highlight a new type of EVs\, referred as tracks\, released by cancer cells during migration and specifically attached along collagen fibers. These tracks\, identified by discoidin receptor 1 (DDR1) enrichment\, are promoted when cell-ECM interactions are increased\, such as in tumors. We characterized these tracks\, their ultrastructure as well as their molecular composition in terms of proteins and nucleic acids\, showing that they are different from classical EVs known so far. Moreover\, these tracks are very stable structures and can be internalized by surrounding cells. After internalization\, they modify the differentiation status and the phenotype of recipient cells\, promoting epithelial to mesenchymal transition\, matrix degradation and invasion. \nThus\, we identified a new class of collagen-associated EVs\, tracks\, that play a role in cell-cell communication by transferring invasive properties. Consequently\, these cancer-related tracks could be a new player in the tumor invasion process. \n\n\n \nAnthony Bouter\nInstitute of Chemistry & Biology of Membranes & Nano-objects • Bordeaux – UMR5248\nBordeaux university \n\n\nInhibition de la réparation membranaire dans la lutte contre la formation de métastases \nLors du processus de métastase\, les cellules cancéreuses invasives sont soumises à des contraintes mécaniques importantes et subissent des dommages de leur membrane plasmique\, l’enveloppe lipidique protectrice qui entoure chacune de nos cellules. Elles ne doivent leur survie qu’à des mécanismes de réparation membranaire exacerbés. Notre objectif est de caractériser cette machinerie et de développer les outils moléculaires capables de l’inhiber et ainsi de limiter l’invasion tumorale et la formation de métastases.
URL:https://www.bricbordeaux.com/en/event/oncosphere-interdisciplinary-seminar-anthony-bouter-and-frederic-saltel/
LOCATION:salle de conférence IBGC – Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/capture-decran-2022-09-01-120628.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220902
DTEND;VALUE=DATE:20220903
DTSTAMP:20220905T085336Z
CREATED:20220902T123543Z
LAST-MODIFIED:20220905T085336Z
UID:20548-1662076800-1662163199@www.bricbordeaux.com
SUMMARY:MIRCADE team. Press article in Inserm Magazine #54
DESCRIPTION:In December 2021\, the team 06 –MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers head by Dr Christophe Grosset published with his collaborators a multidisciplinary article combining 3D imaging\, biology of hepatoblastoma and AI in the journal Communications Biology. \nThe Inserm magazine #54 reviews these major advances in the field of bioarchitectural analysis of tumor tissue\, also called onconanotomy\, with this beautiful article on pages 16 and 17. The entire magazine is available for consultation at this link and the pdf of the article at this link. \n  \nPublication : de Senneville\, Baudouin Denis et al. “Deciphering tumour tissue organization by 3D electron microscopy and machine learning.” Communications biology vol. 4\,1 1390. 13 Dec. 2021\, doi:10.1038/s42003-021-02919-z \nLink to the SBM Departement article about this publication.
URL:https://www.bricbordeaux.com/en/event/mircade-team-press-article-in-inserm-magazine-54/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/article-double-page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220901
DTEND;VALUE=DATE:20221001
DTSTAMP:20220901T074528Z
CREATED:20220901T074528Z
LAST-MODIFIED:20220901T074528Z
UID:20516-1661990400-1664582399@www.bricbordeaux.com
SUMMARY:Golden September
DESCRIPTION:Today starts the Golden September\, all together against childhood cancer. \nIt is an opportunity to support all actions in the fight against childhood cancer: comfort for children in hospital\, families in need and research.
URL:https://www.bricbordeaux.com/en/event/golden-september/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/09/capture-decran-2022-09-01-063619.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220720
DTEND;VALUE=DATE:20220721
DTSTAMP:20220720T084457Z
CREATED:20220720T084457Z
LAST-MODIFIED:20220720T084457Z
UID:20276-1658275200-1658361599@www.bricbordeaux.com
SUMMARY:Article about the MIRCADE team - Médical magazine
DESCRIPTION:Focus on the team working on pediatric cancers (Team 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.)\, led by Christophe Grosset in the June issue of “Médical magazine” (p17).
URL:https://www.bricbordeaux.com/en/event/article-about-the-mircade-team-medical-magazine/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/article-mircade-medical-magazine-titre.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220707T173000
DTEND;TZID=Europe/Paris:20220707T190000
DTSTAMP:20220630T135110Z
CREATED:20220630T135110Z
LAST-MODIFIED:20220630T135110Z
UID:20132-1657215000-1657220400@www.bricbordeaux.com
SUMMARY:Cutaneous Lymphoma Webinar - ELLYE - M. Beylot-Barry presentation
DESCRIPTION:Webinar organized by ELLYE : Ensemble Leucemie Lymphomes Espoir \nAll information and registration are at this link: https://app.livestorm.co/ellye-lymphomes-cutanes/webinaire-lymphomes-cutanes \nNote the intervention of Marie Beylot-Barry\, co-leader ofTeam 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2). \nTitle of the speech: Traitements des lymphomes cutanés : Topiques\, oraux et injectables. Comment\, pourquoi ? Évolution de la réglementation et « liste en sus » \nAsk your questions now: infos@ellye.fr
URL:https://www.bricbordeaux.com/en/event/cutaneous-lymphoma-webinar-ellye-m-beylot-barry-presentation/
LOCATION:visio
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/webinaire-lymphome-cutanes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220707T170000
DTEND;TZID=Europe/Paris:20220707T180000
DTSTAMP:20230316T165233Z
CREATED:20220621T095832Z
LAST-MODIFIED:20230316T165233Z
UID:20004-1657213200-1657216800@www.bricbordeaux.com
SUMMARY:BRIC internal scientific seminar
DESCRIPTION:For reasons of scientific data protection\, the contents of internal seminars are not public. \nUnit members can view the program on the right side of our sharepoint homepage.
URL:https://www.bricbordeaux.com/en/event/bric-internal-scientific-seminar-2/
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/seminaire-scientifique-bric-illustration-generique.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220707
DTEND;VALUE=DATE:20220708
DTSTAMP:20220713T102703Z
CREATED:20220713T102231Z
LAST-MODIFIED:20220713T102703Z
UID:20225-1657152000-1657238399@www.bricbordeaux.com
SUMMARY:Hémangiome-Propranolol publication\, team TRIO2
DESCRIPTION:Read the article written by Candice Ménégon for the SBM Department on the recent publication of theTeam 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2). head by Hamid-Reza Rezvani and Marie Beylot-Barry. \nThe opportunity to focus on research conducted on cutaneous infantile hemangioma and its treatment with propranolol. \nLink to the SBM Department communication \nScientific article: Kaulanjan-Checkmodine\, Priscilla et al. “Is Infantile Hemangioma a Neuroendocrine Tumor?.” International journal of molecular sciences vol. 23\,9 5140. 5 May. 2022\, doi:10.3390/ijms23095140
URL:https://www.bricbordeaux.com/en/event/hemangiome-propranolol-publication-team-trio2/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/focus-article-trio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220704T160000
DTEND;TZID=Europe/Paris:20220704T170000
DTSTAMP:20220622T074005Z
CREATED:20220622T074005Z
LAST-MODIFIED:20220622T074005Z
UID:20015-1656950400-1656954000@www.bricbordeaux.com
SUMMARY:SBM Department Seminar - Alina Chan
DESCRIPTION:Alina Chan\, Broad Institute of MIT & Harvard\, will speak on July 4th at 4pm by videoconference. \nInvited by Andreas Bikfalvi\, team leader of Team 01 – Tumor and vascular biology laboratory. \n“The Origines of COVID-19” \nDr. Alina Chan is a co-author of the book\, VIRAL: The Search for the Origin of Covid-19\, and a researcher with a background in medical genetics\, synthetic biology\, and vector engineering. At the Broad Institute of MIT & Harvard\, Dr. Chan is currently creating next generation vectors for human gene therapy. During the COVID-19 pandemic\, Dr. Chan began to investigate problems relevant to finding the origins of the SARS-CoV-2 virus and in parallel spearheaded the development of the COVID-19 CoV Genetics (covidcg.org) browser for scientists worldwide to rapidly track virus lineages and mutations by locations and date ranges of interest. Her talk will focus on what we know about the origins of COVID. The seminar should be very interesting for everyone.
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-alina-chan/
LOCATION:Visio A. Chan
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/seminaire-alina-chan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220701T130000
DTEND;TZID=Europe/Paris:20220701T170000
DTSTAMP:20220630T115555Z
CREATED:20220603T090647Z
LAST-MODIFIED:20220630T115555Z
UID:19921-1656680400-1656694800@www.bricbordeaux.com
SUMMARY:Defense of Quentin Jehanne's thesis
DESCRIPTION:Thesis defensis of Quentin Jehanne\,team 04 – Helicobacter-associated digestive cancers\, cancer stem cells and therapeutic strategies (C. Varon) \nTitle : “Génomique appliquée à l’étude des infections par les bactéries des genres Campylobacter et Helicobacter“. \nThesis supervised by Philippe Lehours \nFriday\, July 1st at 1pm conference room of the Centre Génomique et Fonctionnelle de Bordeaux (CGFB)\, Carreire site
URL:https://www.bricbordeaux.com/en/event/defense-of-quentin-jehannes-thesis/
LOCATION:salle de conférence CGFB – site Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Thesis defenses
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/photoquentin-jehanne-e1655277518596.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220630T133000
DTEND;TZID=Europe/Paris:20220630T180000
DTSTAMP:20220630T115609Z
CREATED:20220603T093435Z
LAST-MODIFIED:20220630T115609Z
UID:19922-1656595800-1656612000@www.bricbordeaux.com
SUMMARY:NEWMOON kick-off
DESCRIPTION:The NEWMOON Impulse Research Network\, accredited by the University of Bordeaux at the beginning of the year\, is organizing its kick-off on Thursday\, June 30\, from 1:30 to 6:00 p.m. in the Conference Room\, CGFB\, Campus Carreire. \nMany presentations from our researchers during this kick-off meeting! In the order of appearance of the program: \n👉 Pierre Soubeyran\, deputy director of BRIC and member of team 11 – Modeling mechanisms of transformation and resistance in leukemia. \n👉 Audrey Gros\, member of team 05 – Translational research in cutaneous oncology and rare skin diseases (TRIO2). \n👉 Sandrine Dabernat\, co-leader of team 08 – Genetic Biotherapies and Oncology (BioGO). \n👉 Charles Dupin\, member of team 08 – Genetic Biotherapies and Oncology (BioGO). \n👉 Violaine Moreau\, deputy director of BRIC\, co-leader of team 03 – Liver Cancers and Tumor Invasion. \n👉 Lucie Brisson\, co-leader of team 01 – Tumor and Vascular Biology Laboratory. \n👉 Frederic Saltel\, Director of BRIC\, co-leader of team 03 – Liver Cancers and Tumor Invasion. \n  \nMandatory registration : form in link \nProgram: \nNEWMOON kick off 30 juin 13h30 18h CGFB avec inscriptions
URL:https://www.bricbordeaux.com/en/event/newmoon-kick-off/
LOCATION:salle de conférence CGFB – site Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/newmoon.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220628T150000
DTEND;TZID=Europe/Paris:20220628T160000
DTSTAMP:20220622T074336Z
CREATED:20220616T102918Z
LAST-MODIFIED:20220622T074336Z
UID:19923-1656428400-1656432000@www.bricbordeaux.com
SUMMARY:SBM Department Seminar - Sabine Colnot
DESCRIPTION:Sabine Colnot\, Centre de Recherche des Cordeliers\, Paris\, will speak on June 28 at 3:00 pm\, amphitheater 11\, Carreire campus. \nInvited by Violaine Moreau\, team leader of theTeam 03 – Liver Cancers and Tumor Invasion. \n“CRISPR-Cas9-engineered mice developing liver cancers with beta-catenin mutation: towards a better understanding of liver carcinogenesis” \nOne third of hepatocellular carcinoma (HCC) have mutations activating beta-catenin signaling. We definitely showed that these mutations are oncogenic in mice (Loesch et al.\, J Hepatol 2022)\, and are responsible for the development of HCC and mesenchymal hepatoblastoma. This mouse model and a previous one obtained through a loss of function of Apc are valuable preclinical models to better understand why a large subset of beta-catenin activated HCCs are resistant to immunotherapies. Our work further supports the hypothesis that they could be treated based on their metabolism (Gougelet et al.\, Gastroenterol 2019; Senni et al.\, Gut 2019). Lastly\, the CRISPR-Cas9 strategy appears to be an easy-to-use approach to investigate the oncogenic function of specific mutations in HCC.
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-sabine-colnot/
LOCATION:Amphithéâtre 11\, campus Carreire\, 146 rue Léo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/sabine-colnot.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220624T130000
DTEND;TZID=Europe/Paris:20220624T140000
DTSTAMP:20230316T165201Z
CREATED:20220621T095824Z
LAST-MODIFIED:20230316T165201Z
UID:20003-1656075600-1656079200@www.bricbordeaux.com
SUMMARY:BRIC internal scientific seminar
DESCRIPTION:For reasons of scientific data protection\, the contents of internal seminars are not public. \nUnit members can view the program on the right side of our sharepoint homepage.
URL:https://www.bricbordeaux.com/en/event/bric-internal-scientific-seminar/
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/seminaire-scientifique-bric-illustration-generique.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220623T140000
DTEND;TZID=Europe/Paris:20220623T170000
DTSTAMP:20220616T103333Z
CREATED:20220616T103333Z
LAST-MODIFIED:20220616T103333Z
UID:19926-1655992800-1656003600@www.bricbordeaux.com
SUMMARY:Thesis defense Samuel Amintas
DESCRIPTION:Thesis defense of Samuel Amintas\, team 08 Biotherapies Genetics and Oncology BioGO. (S. Dabernat\, F. Moreau-Gaudry) \n  \nTitle : Radiosensibilisation des tumeurs digestives par des molécules bioactives de l’alimentation. \n\nJury:\n\n\n\nMme JAVERZAT\, Sophie\, PR\, Université de Bordeaux\, Présidente\nMme CARRIER\, Alice\, DR\, Université d’Aix-Marseille\, Rapporteure\nMr DELMAS\, Dominiqu\, PR\, Université de Bourgogne\, Rapporteur\nMr ROSSIGNOL\, Rodrigue\, DR\, Université de Bordeaux\, Examinateur\nMr SUPIOT\, Stéphane\, PUPH\, Université de Nantes\, Examinateur\nMme DABERNAT\, Sandrine\, PUPH\, Université de Bordeaux\, Directrice de thèse\n\n  \nA drink will be held in the hall of the faculty of Victory after the defense
URL:https://www.bricbordeaux.com/en/event/thesis-defense-samuel-amintas/
LOCATION:Amphi Favre\, site Victoire\, 3ter Pl. de la Victoire\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,Thesis defenses
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/samuel-amintas-2021-rotated-e1655277401413.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220621T140000
DTEND;TZID=Europe/Paris:20220621T150000
DTSTAMP:20220623T083317Z
CREATED:20220616T103519Z
LAST-MODIFIED:20220623T083317Z
UID:19927-1655820000-1655823600@www.bricbordeaux.com
SUMMARY:SBM Department Seminar: Andreas Bikfalvi
DESCRIPTION:Andreas Bikfalvi\, Head of Team 01 – Tumor and Vascular Biology Laboratory. \n“The notion of Truth in the Biomedical Sciences” \nThe notion of truth has been debated extensively by philosophers and scientists alike for centuries. Relativist and absolutist/objectivist philosophies have a complete different understanding of the value attached to this notion. In this presentation\, I will discuss a number of issues related to the notion of truth in the biomedical sciences. I will first lay out different meanings and forms of truth and then discuss how this relates to the notion of causality. I will then describe how the biomedical science produces “truth” and lay down the different ways to achieve this (induction\, causal inference\, falsification\, Baysian approach\, etc..). \nI will then illustrate this by citing examples from the medical history and present-day biomedical research related to infectious disease\, vascular biology and cancer research. I will then show that a strong relativist epistemology is incompatible with the way biomedical science obtains knowledge. Thus\, in my view\, a realistic notion of truth is central to achieve a sound understanding of physiology and pathology\, and for the development of therapies grounded in a correct knowledge of disease. \nJune 21 at 2 p.m.\, IBGC conference room\, Carreire. \nPhoto ©Gautier DUFAU \nThe recording is online!
URL:https://www.bricbordeaux.com/en/event/sbm-department-seminar-andreas-bikfalvi/
LOCATION:salle de conférence IBGC – Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/photo-a.-bikfalvi-@gautier-dufau.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220617T133000
DTEND;TZID=Europe/Paris:20220617T140000
DTSTAMP:20220616T103704Z
CREATED:20220616T103647Z
LAST-MODIFIED:20220616T103704Z
UID:19928-1655472600-1655474400@www.bricbordeaux.com
SUMMARY:Techno presentation: CYTENA - CELLCYTE X presentation - Full live cell imaging solution
DESCRIPTION:Presentation organized by the BRIC technology group. \npdf document to consult : CELLCYTE X Features & Benefits \nCYTENA – CELLCYTE X presentation – Full live cell imaging solution. \n\nJim Engström\, Field Application Specialist\nJulia Cantarini\, Technical Sales Specialist – Live Cell Analysis – Central Europe\n\nBy videoconference zoom : ID de réunion : 895 4582 4767
URL:https://www.bricbordeaux.com/en/event/techno-presentation-cytena-cellcyte-x-presentation-full-live-cell-imaging-solution/
LOCATION:visio
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/cytena.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220617
DTEND;VALUE=DATE:20220618
DTSTAMP:20220721T101432Z
CREATED:20220721T101432Z
LAST-MODIFIED:20220721T101432Z
UID:20293-1655424000-1655510399@www.bricbordeaux.com
SUMMARY:Donation of Noéline’s parents to the MIRCADE team for the research on diffuse intrinsic pontine glioma (DIPG)
DESCRIPTION:The association “Noeline\, my daughter\, my battle” was created to raise funds to allow Noeline\, 9 years old\, diagnosed with a diffuse intrinsic pontine glioma (DIPG)\, to follow an innovative treatment in clinical trial in the United States. Unfortunately\, Noeline passed away on March 22\, 2022\, 8 months after her diagnosis. As Noeline could not benefit from this treatment\, her parents decided to donate the funds collected to GITC research. Thus\, on June 17\, 2022\, theteam 06 – MIRCADE (Methods and Innovations for Research on Childhood Cancers)\, led by Christophe Grosset received a check for nearly 21 000 € from the association. This donation will be used to finance expenses related to the project of Guillaume Herrault\, a PhD student\, who started his thesis under the supervision of Christophe Grosset in October 2021 after 5 months as a Master 2 student. \nRead the article published in the Dauphiné Libéré on July 2 : https://www.ledauphine.com/sante/2022/07/02/isere-le-pont-de-claix-noeline-une-cagnotte-au-profit-de-la-recherche-contre-le-cancer \nThe Facebook page of the association Noéline\, ma fille\, ma bataille : https://www.facebook.com/No%C3%A9line-ma-fille-ma-bataille-100170252409146
URL:https://www.bricbordeaux.com/en/event/donation-of-noelines-parents-to-the-mircade-team-for-the-research-on-diffuse-intrinsic-pontine-glioma-dipg/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/07/donation-noeline-mircade.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220615T120000
DTEND;TZID=Europe/Paris:20220615T130000
DTSTAMP:20220616T104628Z
CREATED:20220616T104628Z
LAST-MODIFIED:20220616T104628Z
UID:19930-1655294400-1655298000@www.bricbordeaux.com
SUMMARY:Interdisciplinary seminar Oncosphère - Charles Dupin et Julian Boutin
DESCRIPTION:Charles Dupin and Julian Boutin\, Team 08 – Genetic Biotherapies and Oncology (BioGO) will be speaking on June 15 at 12:00 p.m. as part of Oncosphere‘s interdisciplinary seminars via videoconference. \nVideo conferencing link. \n  \n Charles Dupin\, PH \n  Radiothérapie potentialisée par un précurseur de l’hème dans le glioblastome. \nLa radiothérapie est un traitement indispensable du glioblastome\, tumeur cérébrale primitive. Les chirurgiens utilisent depuis une vingtaine d’années un précurseur de l’hème pour visualiser la tumeur en per opératoire. Son accumulation spécifique dans le glioblastome pourrait être utilisée pour sensibiliser la radiothérapie. \nNous avons exploré cette question de la radiosensibilisation in vitro sur des cellules dérivés de patients s’auto-organisant en sphéroïdes. Pour aller plus loin\, des souris imunodéprimées\, implantées en intracérébral ont été irradiées. L’efficacité de ce précurseur de l’hème pour radiosensibiliser a été testé. \n  \n Julian Boutin\, PHU \nThérapie génique anti-cancer par CRISPR-Cas9. \nLa technologie CRISPR-Cas9 permet une très grande efficacité d’édition génique. Ce système pourrait constituer une nouvelle arme anti-cancer très efficace. Des résultats très prometteurs ont été obtenus dans des approches ex vivo pour modifier des lymphocytes (CAR T cells). Nous proposons d’utiliser cette technologie pour modifier le métabolisme tumoral de la biosynthèse de l’hème dans le modèle du cancer de la prostate. Le but est de proposer une alternative thérapeutique innovante: potentialiser les effets de la photothérapie dynamique en l’associant à une thérapie génique.
URL:https://www.bricbordeaux.com/en/event/interdisciplinary-seminar-oncosphere-charles-dupin-et-julian-boutin/
LOCATION:visio
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/seminaire-oncosphere-15-juin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220609T133000
DTEND;TZID=Europe/Paris:20220609T170000
DTSTAMP:20220616T110457Z
CREATED:20220616T110457Z
LAST-MODIFIED:20220616T110457Z
UID:19940-1654781400-1654794000@www.bricbordeaux.com
SUMMARY:Defense of thesis Pauline Michon
DESCRIPTION:Defense of the thesis of Pauline Michon\, team 05 – Translational research in cutaneous oncology and rare skin diseases (TRIO2) (H. Rezvani\, M. Beylot-Barry) \nTitle: Profilage métabolique et immunitaire aux différents stades de la carcinogénèse cutanée. \n  \njeudi 9 juin à 13h30  dans l’amphi Louis à l’ISPED.\nThe defense will take place in person but a zoom link will be available for those who prefer.
URL:https://www.bricbordeaux.com/en/event/defense-of-thesis-pauline-michon/
LOCATION:ISPED\, site Carreire Université de Bordeaux\, 146 rue Leo Saignat\, Bordeaux\, France
CATEGORIES:Meetings,Thesis defenses
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/img-0971.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220531
DTEND;VALUE=DATE:20220601
DTSTAMP:20220616T104928Z
CREATED:20220616T104928Z
LAST-MODIFIED:20220616T104928Z
UID:19931-1653955200-1654041599@www.bricbordeaux.com
SUMMARY:🥇Alnylam Prize Winner - Christine Labreze and François Moisan
DESCRIPTION:Congratulations! \nAt the Annual Scientific Symposium of the Fondation Maladies Rares\, the Alnylam was given to Christine Labreze and François Moisan (Team 05 – Translational research in cutaneous oncology and rare skin diseases – TRIO2)\, for their project “Interfering RNA approach targeting the mutation of the GNAQ gene in vascular anomalies”.
URL:https://www.bricbordeaux.com/en/event/%f0%9f%a5%87alnylam-prize-winner-christine-labreze-and-francois-moisan/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/remise-prix-alnylam-2022-reduit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220523
DTEND;VALUE=DATE:20220524
DTSTAMP:20220616T105127Z
CREATED:20220616T105127Z
LAST-MODIFIED:20220616T105127Z
UID:19932-1653264000-1653350399@www.bricbordeaux.com
SUMMARY:Visit of the new research building - Carreire campus
DESCRIPTION:Visit of our future premises by a delegation of our unit.\nThe new “Research Building” is under construction by the University of Bordeaux on the Carreire site. It will house 7 of our 11 teams.
URL:https://www.bricbordeaux.com/en/event/visit-of-the-new-research-building-carreire-campus/
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/photo_2022-05-23_15-43-00.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220519
DTEND;VALUE=DATE:20220520
DTSTAMP:20220616T105554Z
CREATED:20220615T131531Z
LAST-MODIFIED:20220616T105554Z
UID:19933-1652918400-1653004799@www.bricbordeaux.com
SUMMARY:Publication of Jean-Max Pasquet's team
DESCRIPTION:Read the article written by Candice Ménégon for the SBM Department on the recent publication of Team 10 – Normal and Leukemic Hematopoietic Stem Cells\, directed by Jean-Max Pasquet. \nTargeting autophagy and hematologic mobilization in FLT3-ITD acute myeloid leukemia (1/3 of patients) decreases repopulation capacity and relapse by inducing apoptosis.\nWork carried out thanks to the cell culture device in hypoxia (low oxygen level in the oven and the hood) mimicking the hematopoietic niche. This device is accessible to the scientific community through the CellOxia platform associated with the team. \nLink to the SBM Department communication \nScientific article: Dupont\, Marine et al. “Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells.” Cancers vol. 14\,2 453. 17 Jan. 2022\, doi:10.3390/cancers14020453
URL:https://www.bricbordeaux.com/en/event/publication-of-jean-max-pasquets-team/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/illustration-article-jm-pasquet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220511T090000
DTEND;TZID=Europe/Paris:20220511T173000
DTSTAMP:20230316T165201Z
CREATED:20220422T141729Z
LAST-MODIFIED:20230316T165201Z
UID:18516-1652259600-1652290200@www.bricbordeaux.com
SUMMARY:Scientific day around Michel L. Tremblay (Honoris Causa)
DESCRIPTION:  \nIn the context of the awarding of the title Honoris Causa to Michel L. Tremblay (Goodman Cancer Institute\, McGill University\, Montreal\, Quebec\, Canada) by the University of Bordeaux (May 10 at 5:00 pm)\, Andreas Bikfalvi and the researchers of the unit are organizing a scientific day with the support of the SBM Department\, the day after the awarding. \nThis day includes 2 sessions: \n\nRegenerative medicine & angiogenesis\nCancer\n\nIt will end with a moment of exchange with the students. \nAdmission is free\, subject to availability. \n \n  \n  \n 
URL:https://www.bricbordeaux.com/en/event/scientific-day-around-michel-l-tremblay-honoris-causa/
LOCATION:Amphithéatre de l’IECB\, 2 rue Robert Escarpit\, Pessac\, 33600\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/04/michel-l-tremblay-e1653987284808.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220510T170000
DTEND;TZID=Europe/Paris:20220510T200000
DTSTAMP:20220527T090422Z
CREATED:20220527T090320Z
LAST-MODIFIED:20220527T090422Z
UID:19365-1652202000-1652212800@www.bricbordeaux.com
SUMMARY:Présentation of the Honorary Doctorate Insigna
DESCRIPTION:Michel L. tremblay and Martin J. Blaser were awarded the title of Doctor Honoris Causa by Dean Lewis\, president of the University of Bordeaux after their praises by Andréas Bikfalvi (team 1) and Philippe Lehours (team 4) respectively. \nHonoris Causa\nThe title of Doctor Honoris Causa is awarded to foreign personalities to distinguish them for their contribution to the arts\, literature\, science and technology as well as to France or the establishment that grants the title. \nIn the margin of this event\, Philippe Lehours organized a seminar the day before around Martin J. Blaser (The microbiota as seen by the experts) and Andreas Bikfalvi organized the day after around Michel L. Tremblay. The research of our unit was largely represented in the “cancer” session\, the day ended with a meeting with the students. \nHonoris Causa Program May 10\, 2022 \n  \n[vc_row][vc_column width=’1/2′]\nMichel L. Tremblay\, Dean Lewis\, Andreas Bikfalvi.[/vc_column][vc_column width=’1/2′]\nAcademic speeches of Michel L. Tremblay by Andreas Bikfalvi.[/vc_column][/vc_row][vc_row][vc_column width=’1/2′]\nAcademic speeches of Martin J. Blaser by Philippe Lehours.[/vc_column][vc_column width=’1/2′]\nDean Lewis\, Martin J. Blaser\, Philippe Lehours[/vc_column][/vc_row] \nPhotos ©Gautier DUFAU
URL:https://www.bricbordeaux.com/en/event/presentation-of-the-honorary-doctorate-insigna/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/05/dhc-tremblay-blaser-agora-haut-carre-2022-226--gautier-dufau.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220407
DTEND;VALUE=DATE:20220408
DTSTAMP:20220422T173842Z
CREATED:20220422T173842Z
LAST-MODIFIED:20220422T173842Z
UID:18540-1649289600-1649375999@www.bricbordeaux.com
SUMMARY:Monique Garnier-Semancik 2022 Thesis Prize awarded to Julian Boutin.
DESCRIPTION:During the Scientific Day of the Life and Health Sciences Doctoral School\, the Monique Garnier-Semancik 2022 Thesis Prize was awarded to Julian Boutin for the excellence of his research work on “Securing gene therapy by CRISPR-Cas9 in red blood cell pathologies”. \nJulian did his thesis in the Biotherapie team of the ex BMGIC – U1035\, directed by François Moreau-Gaudry. He defended his thesis in November 2021 and is still part of the team now named Biotherapies Genetics and Oncology #BioGO (team 8) within our unit BRIC-BoRdeaux Institute of onCology. \nJulian holds a position at the Bordeaux University Hospital and in research. He is currently a University Hospital Practitioner. \nCongratulations to Julian Boutin for this thesis award!
URL:https://www.bricbordeaux.com/en/event/monique-garnier-semancik-2022-thesis-prize-awarded-to-julian-boutin/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/04/prix-de-these-julian-Boutin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220404
DTEND;VALUE=DATE:20220405
DTSTAMP:20220616T105730Z
CREATED:20220616T105730Z
LAST-MODIFIED:20220616T105730Z
UID:19937-1649030400-1649116799@www.bricbordeaux.com
SUMMARY:Photo contest
DESCRIPTION:Result of the photo contest realized at the beginning of 2022 within BRIC \n 
URL:https://www.bricbordeaux.com/en/event/photo-contest/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/29-mrc-5-fibroblast-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220331
DTEND;VALUE=DATE:20220402
DTSTAMP:20220623T083332Z
CREATED:20220622T093230Z
LAST-MODIFIED:20220623T083332Z
UID:20029-1648684800-1648857599@www.bricbordeaux.com
SUMMARY:CRISPR and translational medicine meeting
DESCRIPTION:The first CRISPR and Translational Medicine Congress was held on March 31 and April 1st\, 2022 in Bordeaux. \n CRISPR is one of the most powerful discoveries of the last decade and the scientific program of the congress is organized in six sessions dealing with major aspects of current developments: \n\nCRISPR for Neuromuscular Disorders \nEngineered cellular models of genetic disease (cell lines\, primary cells\, iPSCs) \nEngineered animal models of genetic disease \nGene therapy \nSafety (off-targets\, genotoxicity\, immunity)\nNew CRISPR tools\n\nThe CRISPR-Cas9 technology has revolutionized genome edition approaches in the last few years. It is used to model genetic diseases in both in vitro cell lines or primary cells (sessions 1 and 2) and in vivo animal models (session 3). First therapeutic trials in humans have been undertaken (session 4)\, further strengthening the clinical prospects of the technology. Meanwhile\, the intensive use of CRISPR tool in research labs has revealed off-target effects with unwanted genetic modifications (session 5)\, and many current researches are focused on the improvement of DNA targeting and cutting action of CRISPR tools in order to overcome these drawbacks and develop new applications (session 6). \nA round table presenting the CRISPR technology and the societal and ethical aspects was organized on Friday evening. \n\nSpeakers:  \n\nBéatrice Turcq\, chercheuse CNRS\, directrice scientifique de la plateforme CRISP’edit\, vice-présidente de la Société Française de la Génétique\, membre de l’équipe 11 de notre unité\n\nMarion Abecassis\, avocate en sciences de la vie\, membre fondateur d’ARRIGE\, invitée permanente du Comité d’Ethique de l’Inserm (en visio)\nBernard Baertschi\, philosophe\, membre des Comités d’Éthique de l’Inserm et du CENH (Suisse).\n\nLThe round table is moderated by Cyril Sarrauste de Menthière\, ingénieur de recherche CNRS de l’Institut de génétique humaine (IGH\, CNRS et université de Montpellier)\, head of the Scientific Mediation and Valorization Service.  \nOrganizing Committee\, a large part of which is a member of BRIC: \n\nBéatrice Turcq\nAdministrative manager of the congress\nCRHC CNRS\, Responsable Scientifique Plateforme CRISP’edit\, TBMCore\, BRIC INSERM U1312\, équipe 11\nValérie Prouzet-Mauléon\nIE Université de Bordeaux\, Responsable Technique Plateforme CRISP’edit\, TBMCore\, équipe 11\nVirginie Rocher\nAI\, Université de Bordeaux\, Gestion Administrative/Financière/Communication\, TBM-Core UMS CNRS 3427 – US INSERM 005 – Université de Bordeaux\nAurélie Bedel\nMCU-PH\, BRIC INSERM U1312\, équipe 08\nStéphane Duvezin-Caubet\nCRCN CNRS\, IBGC UMR CNRS 5095\nVéronique Guyonnet-Duperat\nIR INSERM\, Responsable Technique Plateforme Vect’UB\, TBMCore\nRichard Iggo\nPU\, BRIC INSERM U1312 \, équipe 07\nSarah Lesjean\nAI INSERM\, Chargée de communication\, BRIC INSERM U1312\, service commun\nCandice Menegon\nChargée de communication\, Département SBM\nFrançois Moreau-Gaudry\nPUPH\, Responsable Scientifique Plateforme Vect’UB\, TBMCore\, BRIC INSERM U1312\, équipe 08\nCyril Sarrauste de Menthiere\nIR CNRS\, Responsable du Service de Médiation Scientifique et Valorisation\, IGH\, UMR 9002 CNRS-Univ. Montpellier\, Montpellier\nEmmanuel Tétaud\nCRCN CNRS\, UMR CNRS 5234
URL:https://www.bricbordeaux.com/en/event/crispr-and-translational-medicine-meeting/
LOCATION:Agora du Haut Carré – Université de Bordeaux\, 43 rue Pierre Noailles\, Talence\, France
CATEGORIES:Meetings,News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/bandeau-simple-crispr-pour-programme.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220328
DTEND;VALUE=DATE:20220329
DTSTAMP:20220616T105806Z
CREATED:20220422T172421Z
LAST-MODIFIED:20220616T105806Z
UID:18534-1648425600-1648511999@www.bricbordeaux.com
SUMMARY:Defense of thesis Lornella Seeneevassen
DESCRIPTION:Lornella Seeneevassen (team 4\, C. Varon) brilliantly defended her thesis. \nSubject: « Targeting Hippo pathway in gastric cancer stem cells »
URL:https://www.bricbordeaux.com/en/event/defense-of-thesis-lornella-seeneevassen/
CATEGORIES:News,Thesis defenses
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/04/thèse-Lornella-C-Varon-à-gauche-Lornella-à-droite-scaled.jpeg
END:VEVENT
END:VCALENDAR